Senior doctors responsible for overseeing cancer care in England and Wales have raised concerns that failures within the National Health Service (NHS) are preventing up to half of patients from receiving the correct treatment for certain cancers.
The National Cancer Audit Collaborating Centre (NatCan) has highlighted significant inconsistencies in care, particularly for prostate, kidney, and colon cancers. Experts warn that these disparities, which vary widely between hospitals, are putting lives at risk.
Shocking Statistics on Cancer Treatment Gaps
NatCan, which monitors nine major cancer types accounting for 80% of cases, has uncovered alarming shortfalls. Data shared reveals:
- 30% of high-risk prostate cancer patients do not receive curative treatment such as surgery or radiotherapy, with performance ranging from 20% to 43% across different hospitals.
- 34% of stage three colon cancer patients do not receive chemotherapy within three months of surgery, with some hospitals exceeding a 60% non-treatment rate.
- 50% of stage four renal cell carcinoma (a type of kidney cancer that has spread) patients do not receive drug treatment, with hospital performance varying between 20% and 85%.
While some patients may decline treatment or be too unwell to undergo intensive therapies, experts argue that these factors do not fully explain the stark variations.
Experts Call for Urgent Action
Professor Ajay Aggarwal, clinical director at NatCan, described the findings as deeply concerning.
“We need to do better. While research into breakthrough treatments is vital, simply ensuring that patients receive the treatments we already have could save and extend lives,” he stated.
According to Prof Aggarwal, factors contributing to the disparity include assumptions that older patients cannot tolerate treatment, inadequate staffing, and smaller hospitals failing to refer patients to specialist centers. Even some leading cancer centers fall short in certain areas.
Tim Mitchell, president of the Royal College of Surgeons, echoed these concerns. “The NHS has access to world-class cancer treatments and care, but inconsistent delivery means far too many patients miss out. In the worst cases, this leads to unnecessary suffering or death,” he warned.
Patient Perspective: A Story of Survival
Ian Pattison, a 70-year-old from Durham, considers himself one of the fortunate ones. Diagnosed with high-risk prostate cancer in 2020, he received the nationally recommended hormone therapy and radiotherapy.
“I was lucky to live near a specialist cancer center in Newcastle. The treatment was brutal, but it saved my life,” he said. Now in remission, he enjoys spending time with his family and grandchildren.
Charities Demand Immediate Reform
Cancer charities argue that addressing these failings is more pressing than reducing wait times.
Eve Byrne of Macmillan Cancer Support called the findings “staggering,” insisting that eliminating treatment disparities should be the top priority of England’s upcoming national cancer strategy.
“Access to the best care should not depend on where you live or which hospital you visit,” she said, highlighting particular concerns for patients from deprived, rural, or ethnically diverse communities.
Amy Rylance from Prostate Cancer UK added: “Patients are being denied their best chance of a cure. This must change now.”
Government Promises Overhaul
NHS England’s cancer director, Prof Peter Johnson, acknowledged the problem, stating: “We know that patient experiences vary too often, and we are working hard to address this.”
The Department of Health and Social Care reiterated its commitment to tackling healthcare inequalities, with a spokesperson confirming a new national cancer strategy would be published later this year. Health Secretary Wes Streeting has pledged that the plan will “revolutionize services.”
A Welsh government spokesperson confirmed efforts are underway to improve cancer care, stating: “The audit highlights areas where further work is needed, and we are committed to delivering necessary improvements.”
With thousands of lives at stake, experts and campaigners insist that urgent reforms are needed to ensure all patients receive the lifesaving treatments they deserve.
This article was created using automation technology and was thoroughly edited and fact-checked by one of our editorial staff members